An Open Label Phase IIa Clinical Study to Evaluate the Safety and Pharmacokinetics of Oral F901318 (Combined With Fluconazole and Posaconazole) in AML

Trial Profile

An Open Label Phase IIa Clinical Study to Evaluate the Safety and Pharmacokinetics of Oral F901318 (Combined With Fluconazole and Posaconazole) in AML

Completed
Phase of Trial: Phase I/II

Latest Information Update: 31 Jul 2017

At a glance

  • Drugs F 901318 (Primary) ; F 901318 (Primary) ; Fluconazole (Primary) ; Posaconazole (Primary)
  • Indications Acute myeloid leukaemia
  • Focus Adverse reactions
  • Acronyms SAFEGUARDFP
  • Sponsors F2G
  • Most Recent Events

    • 31 Jul 2017 Status changed from not yet recruiting to completed.
    • 02 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top